Kura Oncology
KURA
116 hedge funds and large institutions have $529M invested in Kura Oncology in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 54 increasing their positions, 27 reducing their positions, and 10 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 27
90% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 10
8% more funds holding
Funds holding: 107 → 116 (+9)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
2% less capital invested
Capital invested by funds: $541M → $529M (-$11.5M)
8.96% less ownership
Funds ownership: 88.57% → 79.61% (-9%)
30% less call options, than puts
Call options by funds: $263K | Put options by funds: $375K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$13.5M |
| 2 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$11M |
| 3 |
BlackRock
New York
|
+$7.55M |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$5.53M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$20.7M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$9.74M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$6.41M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$3.17M |
| 5 |
SCM
Sio Capital Management
New York
|
-$2.12M |
KURA Hedge Fund Activity: Q3 2018 in Review
116 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q3 2018, worth a combined $529M — down 2.1% from $541M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new KURA positions and 10 closed out — a net gain of 9 holders — while 54 added to existing stakes and 27 trimmed.
The largest buyer was Eagle Asset Management, adding an estimated $13.5M. The largest seller was Fidelity Investments, cutting an estimated $20.7M.
- 116 institutional investors held Kura Oncology (KURA) as of Q3 2018, up from 107 in Q2 2018.
- Funds reported $529M of Kura Oncology stock for Q3 2018, down 2.1% quarter-over-quarter.
- 19 funds opened new Kura Oncology positions in Q3 2018 and 10 closed out, a net change of +9 holders.
- The largest Kura Oncology buyer in Q3 2018 was Eagle Asset Management, an estimated $13.5M added.
- The largest Kura Oncology seller in Q3 2018 was Fidelity Investments, an estimated $20.7M sold.
Based on aggregated 13F filings for Q3 2018.